60 Degrees Pharma gets safety board clearance for babesiosis trial

July 1, 2026 8:02 AM

60 Degrees Pharmaceuticals, Inc. (NASDAQ: SXTP) announced that an independent Data Safety Monitoring Board has recommended continuation of its B-Free ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found